UK markets closed

Biofrontera AG (B8F.DE)

XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
6.80+6.48 (+2,000.00%)
At close: 05:36PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
32,249
32,249
25,738
28,787
30,346
Cost of revenue
6,243
6,243
4,757
3,913
3,536
Gross profit
26,005
26,005
20,981
24,873
26,810
Operating expenses
Research development
7,846
7,846
7,128
7,009
4,789
Selling general and administrative
13,378
13,378
12,262
53,204
29,632
Total operating expenses
21,224
21,224
19,390
60,213
34,421
Operating income or loss
4,781
4,781
1,591
-35,340
-7,611
Interest expense
15
15
163
3,720
3,080
Total other income/expenses net
-
-
-
-
-2,419
Income before tax
-2,127
-2,127
-43,210
35,683
-12,697
Income tax expense
-1,758
-1,758
956
2,397
326
Income from continuing operations
-369
-369
-44,166
33,286
-13,023
Net income
-369
-369
-44,166
37,747
-13,023
Net income available to common shareholders
-369
-369
-44,166
37,747
-13,023
Basic EPS
-0.10
-
-16.17
13.66
-4.82
Diluted EPS
-0.10
-
-16.17
13.46
-4.82
Basic average shares
64,813
-
2,737
2,757
2,697
Diluted average shares
64,813
-
2,737
2,823
2,697